FindTrial
Sign In

Correlation between systemic inflammation indicators and overall survival of patients with COVID-19

Correlation between systemic inflammation indicators and overall survival of patients with COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063644
Enrollment
Unknown
Registered
2022-09-13
Start date
2022-09-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia

Interventions

case series:Nil

Sponsors

Shanghai Fourth People‘s Hospital, School of Medcine, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with COVID-19 admitted to our hospital from 2022.4 to 2022.6

Exclusion criteria

Exclusion criteria: Patients with incomplete data on NLR, SII, PLR, MLR, dNLR, SIRI, CRP, IL-6 and survival outcome (death and time of COVID-19 patients) at admission

Design outcomes

Primary

MeasureTime frame
NLR;SII;PLR;MLR;dNLR;SIRI;CRP;IL-6;survival time;—

Secondary

MeasureTime frame
sex;age;underlying disease;Severity of COVID-19;—

Countries

China

Contacts

Public ContactYu Xiya

Shanghai Fourth People‘s Hospital, School of Medcine, Tongji University

yuxiyash@163.com13764210333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026